Chemocentryx (CCXI) Narrows Q3 Loss to 28c/Share

Chemocentryx (NASDAQ: CCXI) reported Q3 EPS of ($0.28), versus ($2.06) reported last year. Revenue for the quarter came in at $1.13 million, versus $1.44 million reported last year.

For earnings history and earnings-related data on Chemocentryx (CCXI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Piper Sandler Reiterates Overweight Rating on KKR (KKR), 'highest conviction name'
• Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings